About McKinsey's past work for opioid manufacturers

Last updated March 22, 2021

This page provides information about McKinsey & Company’s past work for opioid manufacturers and its response to related issues.

McKinsey has reached agreements with all 50 State Attorneys General, as well as five US territories and the District of Columbia, resolving matters related to our past work for opioid manufacturers. McKinsey first entered into agreements with 49 State Attorneys General, the District of Columbia and five US territories on February 4, 2021. On March 22, 2021, the firm reached a similar agreement with the State of Nevada.

We recognize that our work for opioid manufacturers, while lawful, fell short of the high standards we set for ourselves and that we did not adequately acknowledge the epidemic unfolding in communities across the country. We decided nearly two years ago to end all work on opioid-specific business and have committed to being part of the solution to this serious challenge.

McKinsey has continued to take steps to strengthen its client selection policies, professional standards, and its risk and governance processes to ensure our work is consistent with our values and commitment to social responsibility.

More information about the settlement and changes to our client selection process can be found below.

Additional Resources

Our Client Service Policies

We regularly evaluate and update our governance process, including the policy determining which clients we serve and on what topics.

Our Code of Professional Conduct

See how we bring our values to life for our colleagues and clients.

Social Responsibility

We make our people, expertise, and tools available and work with others to take significant and lasting action on social issues.

New at McKinsey Blog

A collection of stories about our people, our capabilities, our research, and the ever-changing face of our firm.

Contact Us

For media-related inquiries, journalists and other media professionals may use the contact information listed below. We endeavor to respond as quickly as possible and we ask that you do not leave multiple messages.

Email or call +1 (212) 415-1971

For non-media related inquiries, please visit: https://www.mckinsey.com/contact-us